RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Smith & Nephew - Stock

Smith & Nephew Stocks 2024

Smith & Nephew Stocks

873 M

Ticker

SN.L

ISIN

GB0009223206

WKN

502816

In 2024, Smith & Nephew had 873 M outstanding stocks, a 0% change from the 873 M stocks in the previous year.

The Smith & Nephew Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2029e873
2028e873
2027e873
2026e873
2025e873
2024e873
2023873
2022874.51
2021878
2020877
2019877
2018876
2017875
2016893
2015899
2014899
2013906
2012901
2011895
2010889
2009885
2008890
2007928
2006944
2005943
2004941

Smith & Nephew shares outstanding

The number of shares was Smith & Nephew in 2023 — This indicates how many shares 873 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Smith & Nephew earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Smith & Nephew's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Smith & Nephew’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Smith & Nephew's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Smith & Nephew Aktienanalyse

What does Smith & Nephew do?

Smith & Nephew PLC was founded in 1856 by Thomas James Smith in Hull, United Kingdom, as a manufacturer of bandages and orthopedic products. The company has since evolved into a globally operating healthcare company specializing in the manufacturing and distribution of medical devices. The company is divided into three business segments: Orthopaedics, Endoscopy, and Advanced Wound Management. The product range includes a wide range of products used for the treatment of injuries and diseases. This includes artificial joints, instruments for minimally invasive surgery, as well as wound care products such as dressings, compression stockings, and pain therapy systems. The Orthopaedics business segment offers a wide range of products for the treatment of arthritis, joint injuries, and other orthopedic conditions. This includes artificial joints, knee and hip prostheses, and implants for bone fracture stabilization. The company was one of the first to develop an artificial joint prosthesis and has since played a leading role in this field. The Endoscopy business segment provides instruments for minimally invasive surgery. These devices allow surgeons to perform less invasive surgical procedures that allow for faster patient recovery. The product range includes endoscopes, probes, and other instruments used for surgeries in the abdominal cavity, thoracic cavity, joints, and other areas of the body. Smith & Nephew's Advanced Wound Management business segment offers products for effective wound treatment. This includes wound dressings, compression stockings, shoes, and pain therapy systems. These products help reduce healing time and decrease the likelihood of infections. Smith & Nephew is headquartered in London, United Kingdom, and employs over 17,500 people worldwide. The company operates in more than 100 countries and has manufacturing facilities in Europe, Asia, and North America. In 2020, Smith & Nephew's revenue amounted to $4.6 billion. The business model of Smith & Nephew is based on innovation and the development of new technologies. The company invests a significant portion of its revenue each year in research and development to expand and improve its product range. Additionally, the company works closely with doctors and hospitals to better understand patient needs and offer tailored solutions. In recent years, Smith & Nephew has also invested in digital health. The company utilizes innovative technologies such as artificial intelligence and cloud solutions to provide better care and support to patients. This includes the introduction of mobile apps that assist patients in monitoring and self-treating their conditions. In conclusion, Smith & Nephew is a globally operating healthcare company specializing in the manufacturing and distribution of medical devices. The company has a wide product range used for the treatment of injuries and diseases. Its business model is based on innovation and the development of new technologies. Close collaboration with doctors and hospitals, as well as the utilization of digital technologies, are important pillars of the company. Smith & Nephew ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Smith & Nephew's Shares Outstanding

Smith & Nephew's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Smith & Nephew’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Smith & Nephew’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Smith & Nephew’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Smith & Nephew Stock

How many stocks are there of Smith & Nephew?

The current number of stocks of Smith & Nephew is 873 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Smith & Nephew are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Smith & Nephew evolved in recent years?

The number of shares of Smith & Nephew has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Smith & Nephew as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Smith & Nephew?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Smith & Nephew pay?

Over the past 12 months, Smith & Nephew paid a dividend of 0.3 USD . This corresponds to a dividend yield of about 2.44 %. For the coming 12 months, Smith & Nephew is expected to pay a dividend of 0.3 USD.

What is the dividend yield of Smith & Nephew?

The current dividend yield of Smith & Nephew is 2.44 %.

When does Smith & Nephew pay dividends?

Smith & Nephew pays a quarterly dividend. This is distributed in the months of April, November, April, May.

How secure is the dividend of Smith & Nephew?

Smith & Nephew paid dividends every year for the past 0 years.

What is the dividend of Smith & Nephew?

For the upcoming 12 months, dividends amounting to 0.3 USD are expected. This corresponds to a dividend yield of 2.45 %.

In which sector is Smith & Nephew located?

Smith & Nephew is assigned to the 'Health' sector.

Wann musste ich die Aktien von Smith & Nephew kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Smith & Nephew from 5/22/2024 amounting to 0.23 USD, you needed to have the stock in your portfolio before the ex-date on 4/1/2024.

When did Smith & Nephew pay the last dividend?

The last dividend was paid out on 5/22/2024.

What was the dividend of Smith & Nephew in the year 2023?

In the year 2023, Smith & Nephew distributed 0.313 USD as dividends.

In which currency does Smith & Nephew pay out the dividend?

The dividends of Smith & Nephew are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Smith & Nephew stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Smith & Nephew

Our stock analysis for Smith & Nephew Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Smith & Nephew Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.